This is a working overview of AOD9604, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-10. Anything still debated is marked as such rather than presented as settled.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
== External links == Association des medecins rhumatologues du Quebec American College of Rheumatology European League Against Rheumatism Consortium of Rheumatology Researchers of North America, Inc. British Society for Rheumatology Canadian Rheumatology Association Association of Rheumatology Health Professionals (archived 3 March 2009) German Society for Rheumatology
=== Ancient === Perceptions of penis size are culture-specific. Some prehistoric sculptures and petroglyphs depict male figures with exaggerated erect penises. Ancient Egyptian cultural and artistic conventions generally prohibited large penises from being shown in art, as they were considered obscene, but the scruffy, balding male figures in the Turin Erotic Papyrus are shown with exaggerated, large genitals. The Egyptian god Geb is sometimes shown with a massive erect penis and the god Min is almost always shown erect.
=== 1988 to 2011: Reduced again but back on operations === At the end of the Cold War, the TA had a strength of 72,823, including 3,297 in the Home Service Force (HSF). in the 1991 Gulf War 205 Scottish General Hospital was mobilised as a unit based in Riyadh, Saudi Arabia, and a number of TA staff officers and others volunteered and served during the conflict, either in supporting roles in Germany or within 1 (UK) Armoured Division in the Middle East. In December 1991, as part of the reductions in Options for Change, it was announced that the TA's establishment was to be reduced to 63,000, while the HSF element was to be disbanded. In July 1994, this was further reduced to 59,000. The Reserve Forces Act of May 1996 was a landmark reform, making it much easier to call out any element of the Reserves at the behest of the Secretary of State for a range of purposes including 'protection of life or property' well short of the criteria for Queen's Order (e.g. 'great emergency', 'imminent national danger'). It also provides protection in employment law for members' civilian jobs should they be mobilised. This has led to the Army Reserve increasingly providing routine support for the Regular Army overseas including the delivery of composite units to release regular units from standing liabilities; including Bosnia, Kosovo, Cyprus and the Falkland Islands. Some 2,800 TA personnel volunteered for and deployed on Operation Resolute from 1995 to 1998, the UK's contribution to the NATO mission to enforce peace in the Former Yugoslavia.
Sources: en.wikipedia.org
=== Research === Saffron is under preliminary research to assess its potential effect on depression and anxiety. A 2024 review reported that consuming saffron supplements for 8–12 weeks was associated with lowering of some cardiometabolic markers, such as fasting blood glucose, glycated hemoglobin, and blood lipids, in overweight diabetic or prediabetic people.
=== Definition === Aves and a sister group, the order Crocodilia, contain the only living representatives of the reptile clade Archosauria. During the late 1990s, Aves was most commonly defined phylogenetically as all descendants of the most recent common ancestor of modern birds and Archaeopteryx lithographica. However, an earlier definition proposed by Jacques Gauthier gained wide currency in the 21st century, and is used by many scientists including adherents to the PhyloCode. Gauthier defined Aves to include only the crown group of the set of modern birds. This was done by excluding most groups known only from fossils, and assigning them, instead, to the broader group Avialae, on the principle that a clade based on extant species should be limited to those extant species and their closest extinct relatives. Gauthier and de Queiroz identified four different definitions for the same biological name "Aves", which is a problem. The authors proposed to reserve the term Aves only for the crown group consisting of the last common ancestor of all living birds and all of its descendants, which corresponds to meaning number 4 below. They assigned other names to the other groups.
Spectrophotometry: This is a widely used method for measuring the concentration and purity of a DNA sample. Spectrophotometry measures the absorbance of a sample at different wavelengths, typically at 260 nm and 280 nm. The ratio of absorbance at 260 nm and 280 nm is used to determine the purity of the DNA sample. Gel electrophoresis: This technique is used to visualize and compare the size and integrity of DNA samples. The DNA is loaded onto an agarose gel and then subjected to an electric field, which causes the DNA to migrate through the gel. The migration of the DNA can be visualized using ethidium bromide, which intercalates into the DNA and fluoresces under UV light. Fluorometry: Fluorometry is a method to determine the concentration of nucleic acids by measuring the fluorescence of the sample when excited by a specific wavelength of light. Fluorometry uses dyes that specifically bind to nucleic acids and have a high fluorescence intensity. PCR: Polymerase Chain Reaction (PCR) is a technique that amplifies a specific region of DNA, it is also used as a QC method by amplifying a small fragment of the DNA, if the amplification is successful, it means the extracted DNA is of good quality and it's not degraded. Qubit Fluorometer: The Qubit Fluorometer is an instrument that uses fluorescent dyes to measure the concentration of DNA and RNA in a sample. It is a quick and sensitive method that can be used to determine the concentration of DNA samples.
== Early life, family, and education == Pritzker was born in Palo Alto, California, on January 19, 1965. He is the son of Donald Pritzker and Sue Pritzker (née Sandel). Pritzker is named after his paternal uncles, Jay Pritzker and Robert Pritzker, and is known by his initials ("JB" for "Jay Bob"). He has two older siblings: Anthony and Penny, the latter of whom served as the United States Secretary of Commerce under Barack Obama. Pritzker is a member of the Pritzker family, a Jewish family of Ukrainian descent that was prominent in business and philanthropy during the late 20th century. The Pritzkers have consistently ranked near the top of the Forbes "America's Richest Families" list since its inception in 1982. Pritzker was raised in Atherton, California. His father, Donald, was the president of Hyatt, a hotel chain owned by the Pritzker family. Donald was credited with growing Hyatt into the nation's fifth-largest hotel chain at the time of his death. Pritzker's parents were also active in Democratic politics in California. Pritzker later credited this exposure with spurring his own interest in politics. In 1972, Donald Pritzker died of a heart attack at age 39. After his father died, Pritzker's mother struggled with alcoholism and depression. As a result, at age 12, Pritzker moved to Chicago to live with his aunt and uncle, Jay and Cindy Pritzker. He graduated from Milton Academy, a boarding school in Massachusetts, and attended Georgetown University before transferring to Duke University, from which he graduated with a Bachelor of Arts in political science.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.